L
Lemah Creek Clinical Research | Oakbrook Terrace, IL
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Quetiapine XR
TAK-062
Semaglutide
Olorinab
Seltorexant
TAK-101
Guselkumab
Mirikizumab
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 7 total trials
The purpose of this study is to evaluate the efficacy and safety of guselkumab in participants with Crohn's disease.
Active, not recruiting
Crohn Disease
Drug: Guselkumab Dose 3
Drug: Placebo
The main aim is to see how TAK-062 works to reduce celiac-related symptoms and improve small intestinal damage due to gluten exposure, in participant...
Active, not recruiting
Celiac Disease
Drug: TAK-062 Placebo
Dietary Supplement: Simulated Inadvertent Gluten Exposure (SIGE) Gluten-free Bar
The main aim of the study is to assess if TAK-101 can reduce gluten related symptoms and immune activation in adult participants with celiac disease...
Enrolling
Celiac Disease
Dietary Supplement: Gluten
Drug: TAK-101
Trial sponsors
A
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems